Hypertension and diabetes in obesity.
作者信息
Masuo Kazuko, Tuck Michael L, Lambert Gavin W
机构信息
Human Neurotransmitters Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, VIC 8008, Australia.
出版信息
Int J Hypertens. 2011;2011:695869. doi: 10.4061/2011/695869. Epub 2011 Jun 20.
Abstract
摘要
相似文献
1
Hypertension and diabetes in obesity.
Int J Hypertens. 2011;2011:695869. doi: 10.4061/2011/695869. Epub 2011 Jun 20.
2
Obesity, diabetes and hypertension associated with antipsychotic use in remitted schizophrenia.
Int J Risk Saf Med. 2011;23(3):181-5. doi: 10.3233/JRS-2011-0536.
3
[Obesity, hypertension and diabetes mellitus in patients with endometrial cancer]].
Ginekol Pol. 2003 Apr;74(4):274-81.
4
Diabetes, but Not Hypertension and Obesity, Is Associated with Postoperative Cognitive Dysfunction.
Dement Geriatr Cogn Disord. 2018;46(3-4):193-206. doi: 10.1159/000492962. Epub 2018 Oct 16.
5
Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: part A: mechanisms of obesity induced hypertension, diabetes and dyslipidemia and practice guidelines for treatment.
J Hypertens. 2018 Jul;36(7):1427-1440. doi: 10.1097/HJH.0000000000001730.
6
Cardiovascular and renal complications of type 2 diabetes in obesity: role of sympathetic nerve activity and insulin resistance.
Curr Diabetes Rev. 2010 Mar;6(2):58-67. doi: 10.2174/157339910790909396.
7
Solitary and combined negative influences of diabetes, obesity and hypertension on health-related quality of life of elderly individuals: A population-based cross-sectional study.
Diabetes Metab Syndr. 2016 Apr-Jun;10(2 Suppl 1):S37-42. doi: 10.1016/j.dsx.2016.01.018. Epub 2016 Jan 14.
8
High prevalence of diabetes mellitus, hypertension and obesity among persons with a recorded diagnosis of intellectual disability or autism spectrum disorder.
J Intellect Disabil Res. 2018 Apr;62(4):269-280. doi: 10.1111/jir.12462. Epub 2017 Dec 26.
9
Prevalence of obesity and systemic hypertension among diabetes mellitus patients attending an out-patient diabetes clinic in a Ghanaian Teaching Hospital.
Diabetes Metab Syndr. 2014 Apr-Jun;8(2):67-71. doi: 10.1016/j.dsx.2014.04.036. Epub 2014 May 21.
10
Body mass index, diabetes, hypertension, and short-term mortality: a population-based observational study, 2000-2006.
J Am Board Fam Med. 2012 Jul-Aug;25(4):422-31. doi: 10.3122/jabfm.2012.04.110289.
引用本文的文献
1
Body Mass Index in Late Adolescence and Later Life Kidney Outcomes: A Population-Based Cohort Study in Swedish Men.
Kidney Med. 2025 Feb 13;7(4):100982. doi: 10.1016/j.xkme.2025.100982. eCollection 2025 Apr.
2
Assessment of electrolytes, markers of glycaemic control and renal dysfunction among adult Nigerians recently diagnosed with type 2 diabetes mellitus.
Afr Health Sci. 2022 Sep;22(3):296-306. doi: 10.4314/ahs.v22i3.31.
3
The triumvirate: why hypertension, obesity, and diabetes are risk factors for adverse effects in patients with COVID-19.
Acta Diabetol. 2021 Jul;58(7):831-843. doi: 10.1007/s00592-020-01636-z. Epub 2021 Feb 15.
4
Effect of Enzymatic Treatment of Linné Extracts on Lipid Accumulation and Adipogenesis in High-Fat-Diet-Induced Obese Male Mice.
Nutrients. 2019 Jan 25;11(2):269. doi: 10.3390/nu11020269.
5
Integrating Mobile Fitness Trackers Into the Practice of Medicine.
Am J Lifestyle Med. 2016 Jul 8;11(1):77-79. doi: 10.1177/1559827615583643. eCollection 2017 Jan-Feb.
6
Frequency and co-prescription pattern of Chinese herbal products for hypertension in Taiwan: a Cohort study.
BMC Complement Altern Med. 2015 Jun 6;15:163. doi: 10.1186/s12906-015-0690-8.
7
Trends in the treatment of hypertension from the perspective of traditional chinese medicine.
Evid Based Complement Alternat Med. 2013;2013:275279. doi: 10.1155/2013/275279. Epub 2013 Jun 26.
本文引用的文献
1
Roles of beta2- and beta3-adrenoceptor polymorphisms in hypertension and metabolic syndrome.
Int J Hypertens. 2010 Oct 21;2010:832821. doi: 10.4061/2010/832821.
2
Sympathetic nervous system activity is associated with obesity-induced subclinical organ damage in young adults.
Hypertension. 2010 Sep;56(3):351-8. doi: 10.1161/HYPERTENSIONAHA.110.155663. Epub 2010 Jul 12.
3
The role of sympathetic nervous activity in renal injury and end-stage renal disease.
Hypertens Res. 2010 Jun;33(6):521-8. doi: 10.1038/hr.2010.35. Epub 2010 Mar 26.
4
HOMA insulin sensitivity index and the risk of all-cause mortality and cardiovascular disease events in the general population: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab) study.
Diabetologia. 2010 Jan;53(1):79-88. doi: 10.1007/s00125-009-1588-0. Epub 2009 Nov 7.
5
Mechanisms of sympathetic activation in obesity-related hypertension.
Hypertension. 2006 Nov;48(5):787-96. doi: 10.1161/01.HYP.0000242642.42177.49. Epub 2006 Sep 25.
6
Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001.
JAMA. 2003 Jan 1;289(1):76-9. doi: 10.1001/jama.289.1.76.
7
Obesity-related hypertension: role of the sympathetic nervous system, insulin, and leptin.
Curr Hypertens Rep. 2002 Apr;4(2):112-8. doi: 10.1007/s11906-002-0035-0.
8
Noradrenaline release and the pathophysiology of primary human hypertension.
Am J Hypertens. 1989 Mar;2(3 Pt 2):140S-146S. doi: 10.1093/ajh/2.3.140s.
Zotero 插件